{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:42:44Z","timestamp":1792176164680,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of antiseizure medication in patients with epilepsy is one of the significant risk factors associated with abnormal vitamin D status. We aimed to identify risk factors related to hypovitaminosis D in pediatric patients treated with antiseizure medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A cross-sectional retrospective cohort study was conducted on 127 pediatric epilepsy patients who received antiseizure drugs from December 2021 to December 2022. Demographic data, seizure types, diet, physical activity, duration, and types of antiseizure medications were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 127 patients in this study, 53% were male, and the mean age was 9,1\u2009\u00b1\u20094,6\u00a0years (range: 2\u201317). The mean serum 25(OH)D level at baseline in winter\/autumn was 24,2\u2009\u00b1\u200914,2\u00a0ng\/mL; 47.0% of the patients were 25(OH) D deficient, 23% were 25(OH)D insufficient, and 30% had a vitamin D level within the normal range. The vitamin 25(OH) D level was 27,6\u2009\u00b1\u200912,2 in the epilepsy group with non-enzyme-induced antiseizure drugs, 21,76\u2009\u00b1\u200919,7 in the group with enzyme-induced antiseizure drugs, and 13,96\u2009\u00b1\u20097,9 in the group with combined antiseizure drugs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The number of antiseizure drugs, treatment with enzyme-induced antiseizure drugs, duration of epilepsy, abnormalities in magnetic resonance imaging, and etiology play important roles in determining the vitamin D level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-01898-9","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T22:53:16Z","timestamp":1739141596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vitamin D status of pediatric epilepsy patients and evaluation of affecting factors"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-3363","authenticated-orcid":false,"given":"Serap","family":"Bilge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema Nur","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"1898_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.seizure.2019.06.009","volume":"71","author":"Zejun Xua","year":"2019","unstructured":"Xua Zejun, Jinga Xia, Lia Guizhou. Valproate decreases vitamin D levels in pediatric patients with epilepsy. Seizure. 2019;71:60\u20135.","journal-title":"Seizure."},{"key":"1898_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1186\/s12889-021-11888-1","volume":"21","author":"HS Mahbubul","year":"2021","unstructured":"Mahbubul HS, Badhan B, Umme RS. High prevalence of vitamin D deficiency among the South Asian adults: a systematic review and meta-analysis. BMC Public Health. 2021;21:1823.","journal-title":"BMC Public Health."},{"key":"1898_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12887-021-02906-7","volume":"21","author":"N Likasitthananon","year":"2021","unstructured":"Likasitthananon N, Nabangchang C, Simasathien T. Hypovitaminosis D and risk factors in pediatric epilepsy children. BMC Pediatr. 2021;21:432.","journal-title":"BMC Pediatr."},{"issue":"2","key":"1898_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1684\/epd.2021.1268","volume":"23","author":"IA Cunha","year":"2021","unstructured":"Cunha IA, Saraiva MA, Lopes P, Jesus-Ribeiro J. Vitamin D deficiency in a Portuguese epilepsy cohort: who is at risk and how to treat. Epileptic Disord. 2021;23(2):291\u20138.","journal-title":"Epileptic Disord."},{"key":"1898_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clineuro.2016.04.019","volume":"146","author":"O Albaghdadi","year":"2016","unstructured":"Albaghdadi O, Alhalabi MS, Alourfi Z. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy. Clin Neurol Neurosurg. 2016;146:52\u20136.","journal-title":"Clin Neurol Neurosurg."},{"key":"1898_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jped.2020.01.004","volume":"96","author":"C Junges","year":"2020","unstructured":"Junges C, Machado TD, Filho PRSN, Riesgo R, de Mello ED. Vitamin D deficiency in pediatric patients using antiepileptic drugs: Systematic review with meta-analysis. J de Pediatr. 2020;96:559\u201368.","journal-title":"J de Pediatr"},{"issue":"3","key":"1898_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319\u201329.","journal-title":"Chem Biol"},{"issue":"1","key":"1898_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneurol.2010.341","volume":"68","author":"N Jett\u00e9","year":"2011","unstructured":"Jett\u00e9 N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD. Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol. 2011;68(1):107\u201312.","journal-title":"Arch Neurol"},{"issue":"8","key":"1898_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","volume":"108","author":"DL Teagarden","year":"2014","unstructured":"Teagarden DL, Meador KJ, Loring DW. Low vitamin D levels are common in patients with epilepsy. Epilepsy Res. 2014;108(8):1352\u20136.","journal-title":"Epilepsy Res"},{"issue":"2","key":"1898_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/2249-4863.192338","volume":"5","author":"E Arora","year":"2016","unstructured":"Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: Monitoring, treatment, and prevention strategies are needed. J Family Med Prim Care. 2016;5(2):248\u201353.","journal-title":"J Family Med Prim Care"},{"issue":"11","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/children9111696","volume":"9","author":"RA Khalifah","year":"2022","unstructured":"Khalifah RA, Hamad MH, Hudairi A. Prevalence and Related Risk Factors of Vitamin D Deficiency in Saudi Children with Epilepsy. Children. 2022;9(11):1696.","journal-title":"Children."},{"issue":"8","key":"1898_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/epi.13443","volume":"57","author":"Choong Yi Fong","year":"2016","unstructured":"Choong Yi Fong. Ann Nie Kong, Bee Koon Poh, Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia. 2016;57(8):1271\u20139.","journal-title":"Epilepsia"},{"issue":"2","key":"1898_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3349\/ymj.2014.55.2.417","volume":"55","author":"JH Baek","year":"2014","unstructured":"Baek JH, Seo YH, Kim GH, Kim MK, Eun BL. Vitamin D levels in children and adolescents with antiepileptic drug treatment. Yonsei Med J. 2014;55(2):417\u201321.","journal-title":"Yonsei Med J"},{"issue":"3","key":"1898_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/0883073812472256","volume":"29","author":"CY Fong","year":"2014","unstructured":"Fong CY, Riney CJ. Vitamin D deficiency among children with epilepsy in South Queensland. J Child Neurol. 2014;29(3):368\u201373.","journal-title":"J Child Neurol."},{"issue":"9","key":"1898_CR15","doi-asserted-by":"publisher","first-page":"968868","DOI":"10.3389\/fnut.2022.968868","volume":"29","author":"Na Dong","year":"2022","unstructured":"Dong Na, Guo H-L, Ya-Hui Hu. Association between serum vitamin D status and the anti-seizure treatment in Chinese children with epilepsy. Front Nutr. 2022;29(9):968868.","journal-title":"Front Nutr"},{"key":"1898_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.eplepsyres.2017.11.013","volume":"139","author":"T Dur\u00e1-Trav\u00e9","year":"2018","unstructured":"Dur\u00e1-Trav\u00e9 T, Gallinas-Victoriano F, Malumbre M. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy. Epilepsy Res. 2018;139:80\u20134.","journal-title":"Epilepsy Res"},{"issue":"6","key":"1898_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/00207454.2013.847836","volume":"124","author":"A Holl\u00f3","year":"2014","unstructured":"Holl\u00f3 A, Clemens Z, Lakatos P. Epilepsy and vitamin D. Int J Neurosci. 2014;124(6):387\u201393.","journal-title":"Int J Neurosci"},{"key":"1898_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12098-021-03853-y","volume":"89","author":"M Vijayakumar","year":"2022","unstructured":"Vijayakumar M, Ajitha BK, George B, Bhatia V. Vitamin D Status in Children on Anticonvulsant Therapy. Indian J Pediatr. 2022;89:541\u20135.","journal-title":"Indian J Pediatr."},{"issue":"8","key":"1898_CR19","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","volume":"108","author":"DL Teagarden","year":"2014","unstructured":"Teagarden DL, Meador KJ, Loring DW. Low Vitamin D Levels Are Common in Patients with Epilepsy. Epilepsy Res. 2014;108(8):1352\u20136.","journal-title":"Epilepsy Res"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01898-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T10:40:18Z","timestamp":1739184018000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01898-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01898-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4624819\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards established in the Declaration of Helsinki and its later amendments or comparable ethical standards and approved by the Clinical Research Ethics Committee of Gazi Y\u015fargilEducation & Research Hospital (2023:2023\/353). Written informed consent was obtained from all the participants and\/or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}